ANAVEX LIFE SCIENCES CORP. (NASDAQ:AVXL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of October 1, 2017, Anavex Life Sciences Corp., a Nevada corporation (the “Company”), entered into an Amended and Restated Employment Agreement (the “Amended Agreement”) with Sandra Boenisch, in her continuing capacity as Principal Financial Officer of the Company. The Amended Agreement replaces the prior employment agreement with Ms. Boenisch, dated September 17, 2015 (the “Original Agreement”), which expired as of October 1, 2017.
The Amended Agreement provides for a base salary of $120,000 CAD and clarifies certain of Ms. Boenisch’s duties to the Company, but is otherwise materially similar to the Original Agreement. The Original Agreement is filed as Exhibit 10.92 to the Company’s Annual Report on Form 10-K, filed on December 29, 2015 and is incorporated herein by reference.
